Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin as Add-on to Metformin in Type 2 Diabetes
NCT00860288Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00860288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860288.